{"task_id": "1fe4776a839920ba", "source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 225/464)", "text": "D PROGNOSTIC ISSUES (CONT\u2019D)\n214\nTesticular Cancer\n\n--- Page 236 ---\nBrain Tumors\nSee BRAIN TUMORS (p. 297)\nOvarian Cancer\nPATHOPHYSIOLOGY\nHISTOLOGIC TYPE\n\u0002\nEPITHELIAL (90%)\n\u0002\nSEROUS CYSTADENOCARCINOMA (75 80%)\n\u0002\nMUCINOUS CYSTADENOCARCINOMA (10%)\n\u0002\nENDOMETRIOID CARCINOMA (10%)\n\u0002\nCLEAR CELL (<5%)\n\u0002\nUNDIFFERENTIATED (<1%)\n\u0002 BRENNER\u2019S TUMOR (<1%)\n\u0002\nMIXED EPITHELIAL TUMOR\n\u0002\nMALIGNANT\nMIXED\nMULLERIAN\nTUMORS\n(carcinosarcomas)\n\u0002\nUNCLASSIFIED\n\u0002\nGERM CELL TUMORS\n\u0002\nDYSGERMINOMA (ovarian counterpart of semi\nnoma of the testes)\n\u0002\nENDODERMAL SINUS TUMOR\n\u0002\nEMBRYONAL CARCINOMA\n\u0002\nPOLYEMBRYOMA\n\u0002\nCHORIOCARCINOMA\n\u0002\nTERATOMA\n\u0002\nMIXED\n\u0002\nSEX CORD STROMAL TUMORS\n\u0002\nSERTOLI\u2013LEYDIG CELL TUMOR\n\u0002\nGRANULOSA STROMAL CELL TUMOR\n\u0002\nGYNANDROBLASTOMA\n\u0002\nANDROBLASTOMA\n\u0002\nUNCLASSIFIED\nRISK FACTORS FOR EPITHELIAL OVARIAN CANCER\n\u0002\nPERSONAL\nAshkenazi Jews (BRCA1/2), HNPCC,\nCaucasian, nulliparity (incessant ovulation)\n\u0002\nFAMILY HISTORY\nbreast cancer, ovarian cancer\n\u0002\nDISEASES\nbreast cancer, endometrial cancer\nCLINICAL FEATURES\nSYMPTOMS\n\u0002\nLOCOREGIONAL\nbowel\nobstruction,\nconstipation,\nabdominal pain, abdominal mass, abdominal bloat\ning/distension, renal failure, urinary frequency\n\u0002\nMETASTATIC\ncough\n\u0002\nCONSTITUTIONAL\nweight loss, weight gain (if\nascites and edema), anorexia, fatigue\n\u0002\nPARANEOPLASTIC\nneurologic (peripheral neuropa\nthy, dementia, ALS like syndrome, cerebellar\nataxia), Cushing\u2019s syndrome, hypercalcemia (clear\ncell), thrombophlebitis\nSTAGING\nFIGO STAGING\nSTAGE I (15%)\nlimited to the ovaries; 80% 5 year\nsurvival\n\u0002 IA=one ovary involved with no ascites\n\u0002 IB=both ovaries involved with no ascites\n\u0002 IC=IA or IB with tumor on the ovary surface,\nruptured capsule, positive pelvic washings\nSTAGE II (15%)\npelvic extension; 60% 5 year\nsurvival\n\u0002 IIA=extension to uterus or tubes\n\u0002 IIB=extension to other pelvic tissues\n\u0002 IIC=IIA or IIB with tumor on the ovary sur\nface,\nruptured\ncapsule,\npositive\npelvic\nwashings\nSTAGE III (65%)\nperitoneal implants outside\nthe pelvis with extensions to small bowel, omen\ntum, or liver (serosal surface only); 30% 5 year\nsurvival\n\u0002 IIIA=tumor grossly limited to the true pelvis\nwith negative nodes, but microscopic seeding\nof abdominal peritoneal surfaces\n\u0002 IIIB=abdominal peritoneal implants <2 cm\n\u0002 IIIC=abdominal peritoneal implants >2 cm, ret\nroperitoneal/inguinal lymph nodes\nSTAGE IV (5%)\ndistant metastasis; 10% 5 year\nsurvival\n\u0002 IV=liver\nparenchyma,\nperipheral\nsuperficial\nlymph nodes, cytology positive pleural effusion\nOVERALL SURVIVAL BY STAGE\nStage\nFIGO stage\nFreq\n5 year survival\nI\nIA C\n35%\n80 90%\nII\nIIA C\n5%\n60 70%\nIII\nIIIA C\n40%\n30 50%\nIV\nIV\n10%\n20%\nINVESTIGATIONS\nBASIC\n\u0002\nLABS\nCBCD, lytes, urea, Cr, AST, ALT, ALP, bilir\nubin, Ca, albumin, CA125, bhCG, aFP\n\u0002\nIMAGING\nCXR, U/S abd, CT abd/pelvis\n\u0002\nBIOPSY\nlaparoscopy, staging laparotomy\nOvarian Cancer\n215", "text_length": 2787, "metadata": {"source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 225/464)", "type": "chunk", "chunk_index": 224, "total_chunks": 464, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T18:40:09.556332", "document_uuid": "fda2cab4-cdd9-4015-af24-46fd62c86d94", "filename": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf", "category": "medical_pdf", "section": "body", "year": null, "outdated": false, "document_id": "fda2cab4-cdd9-4015-af24-46fd62c86d94"}, "created_at": "2025-12-11T18:40:09.557069", "status": "complete", "chunks_added": 2}